Xgeva 120 mg / 1.7 ml, 1 vial (Denosumab 120 mg / 1.7 ml) by Amgen.
Indications: Prevention of skeletal-related events in adults with bone metastases from solid tumours; giant cell tumour of bone.
Administration: Subcutaneous injection of 120 mg every 4 weeks with calcium and vitamin D supplementation.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Amgen |
| Active ingredient | Denosumab 120 mg / 1.7 ml (70 mg/ml) — RANKL inhibitor. |
| Strength & pack | 1 single-use vial. |
| Form | Solution for injection |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |